About 3 million FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors manufactured by Abbott were recalled in November, ...

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...

Add Yahoo as a preferred source to see more of our stories on Google. This image provided by Abbott’s Lingo division in July 2025, shows the Lingo wearable device for continuous glucose monitoring.

Add Yahoo as a preferred source to see more of our stories on Google. In this photo illustration, we see a close-up of the midsection and legs of woman with an arm tattoo holding a smartphone and an ...

There was a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with Type 2 diabetes from 2021-23.

Should A1c remain the gold standard for routine monitoring of glucose control in people with diabetes, or is it time to shift ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Researchers have found in a new study that continuous glucose monitoring (CGM) in the ICU appears to provide reliable glucose ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Publisher's note: This material was paid for by CCS Medical and provided by CCS Medical. The views expressed by the author are their own. This material is not part of Health Affairs Forefront; it has ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, ...

Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...